EMPALIX L (25/5)

EMPALIX L (25/5) contains Empagliflozin 25 mg + Linagliptin 5 mg, a well-balanced combination for managing type 2 diabetes. Empagliflozin helps eliminate excess glucose through urine, while Linagliptin enhances insulin secretion and reduces glucose production. Together, they provide effective and sustained glycemic control without significant risk of hypoglycemia, along with added benefits of weight management and cardiovascular support.